The Medicinal Mushroom Dispensary

psilocybin canada


Microdosing psilocybin ressources

How One Year of Microdosing Helped My Career, Relationships, and Happiness Better Humans, September 2017 “My perspective on psychedelics quickly changed, and they became a vehicle for greater self-reflection and awareness. Psychedelics appealed to me in their ability to work through painful emotions of the past.” Psilocybin, the Active Ingredient in ’Shrooms, Is Looking More and More Like a Potential Wonder Drug The Cut, December 2016 “In a surprising number of cases, a single dose of psilocybin can lead to lasting improvements to mental health and the abatement of serious psychological issues.” How to have a better death with psilocybin mushrooms Third Wave, January 2017 “Recently, psychiatrists and therapists have turned to the classic psychedelic psilocybin as a potential salve for end-of-life anxiety. Psychiatrists have known for half a century that classic psychedelics often provide a new perspective on life, as a result of the peak/mystical experience.” Everything You Wanted To Know About Microdosing (But Were Afraid To Ask) Huffington Post, January 2016 “Fadiman is examining the effects of administering psychedelic drugs like LSD and psilocybin in amounts so small that they are below the perceptual threshold. As part of an ongoing research project, Fadiman is collecting the self-reported testimonies of hundreds of people from around the globe.” Why I Take Psychedelic Mushrooms For My Health Refinery 29, December 2015 “I’m on mushrooms right now. Just a small amount, about half the size of my pinky nail. I’m not hallucinating or anything, but for the past couple of months, I’ve been taking a regular, tiny dose of psilocybin ‘shrooms every few days. And life has never been better. It’s called “microdosing” — and, so far, it’s been awesome.” How and why people ‘microdose’ tiny hits of psychedelic drugs CBC News, August 2018 “They found that microdosers scored higher on both creativity and wisdom, and lower on negative emotionality and dysfunctional attitude tied to depression and anxiety.” I Reset My Brain with Magic Mushrooms Medium, May 2018 “If someone said you could take a simple drug that in five hour’s time would not only reset your brain, erasing years of depressive and anxious feelings, but also generally lift your mood, seemingly permanently, would you do it? I did.” Microdosing’s Micromoment: Guide and Explainer The Cut, May 2018 “Consuming crumb-size amounts of psychedelics — not to get high but to feel more focused and creative and present — has moved a tiny bit mainstream.” Magic mushroom chemical psilocybin could be key to treating depression The Guardian, December 2016 “Immediate reduction in depression and anxiety for up to eight months seen in patients with advanced cancer given a single dose of psilocybin.” Scientists Are Starting to Test Claims about “Microdosing” Scientific American, August 2018 “Dennis van der Meijden isn’t aiming to see the face of God, feel one with the cosmos, grasp the hidden reality of time and space, or embark on a sacred journey. What the Dutch graphic designer, producer, and rapper wants — and gets — from his twice-weekly ‘microdoses’ of psilocybin is more modest.” New Study on Microdosing Psychedelics Shows Why Scientists Are Excited Alternet, November 2018 “A pair of Canadian researchers have just completed a study comparing people who microdose—the act of taking very small quantities of psychedelic drugs such as LSD or magic mushrooms—with those who don’t. They found that microdosers scored higher on key measures of mental health and well-being.” Microdosers Are More Creative With Happier Emotions, Study Finds Vice, November 2018 “Two PhD students in Ontario conducted one of the first-ever studies on microdosing. They found that some of what microdosers rave about seems to hold true. Magic mushroom users eager to talk CBC News, February 2018 “Shaw expects to have results of her survey within a few months, but she has been struck by the overwhelming positive and sometimes transformative experiences with magic mushrooms that people have described to her” The renaissance in psychedelic science is here! Globe & Mail, June 2018 “Researchers are examining the potential of drugs like LSD and psilocybin – recreational drugs mostly associated with the 1960s counterculture – to act as psycho-therapeutic tools in the treatment of severe addictions, end-of-life anxiety, depression, and post-traumatic stress disorder. Truth be told, many of the new findings are in fact old discoveries.” Vancouver forges new paths in revival of psychedelic research Georgia Straight, January 2018 “The B.C. Centre on Substance Use has assembled a team that’s positioning Vancouver as a global force in investigating mind-altering drugs for the treatment of addiction and mental disorders.” A Radical New Approach to Beating Addiction Psychology Today, May 2017 “Psychedelic drugs are in the vanguard of treatment for addiction, raising the paradoxical question of how one mind-altering substance can override dependence on another.”

For more scientific studies into psilocybin therapy follow this link.
Microdosing psychedelic drugs associated with increases in conscientiousness and reductions in neuroticism 
Journal of Psychedelic Studies, April 2021
First head-to-head trial pits psychedelic therapy against antidepressant  
New England Journal of Medicine, April 2021
International study finds 79% of individuals who microdose with psychedelics report improvements in their mental health
Psychopharmacology, October 2020

Journal of Palliative Medicine, April 2018

“With an expanding evidence base confirming safety and benefits… it is time to revisit the legitimate therapeutic use of psychedelics.”

An interview study of psychedelic microdosing.
Nordic Studies on Alcohol and Drugs, February 2018

“Respondents generally agreed that proper microdoses did not result in any intoxication. The majority reported some effect that they regarded as positive. The most commonly described effects were health related, with a benign influence noted especially on states of depression and anxiety.”

“Therapeutic effect was also reported for pain management and for a range of conditions including obsessive-compulsive disorder (OCD), post-traumatic stress disorder (PTSD), narcolepsy, and migraines.”

Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial.
Journal of Psychopharmacology, November 2016

“…psilocybin produced large decreases in clinician- and self-rated measures of depressed mood and anxiety, along with increases in quality of life, life meaning, and optimism, and decreases in death anxiety. At 6-month follow-up, these changes were sustained…”

Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer.
Journal of Psychopharmacology, November 2016

“…psilocybin produced immediate, substantial, and sustained improvements in anxiety and depression and led to decreases in cancer-related demoralization and hopelessness, improved spiritual wellbeing, and increased quality of life.”

The Lancet, May 2016
“Psilocybin was well tolerated by all of the patients, and no serious or unexpected adverse events occurred. Relative to baseline, depressive symptoms were markedly reduced 1 week and 3 months after treatment. Marked and sustained improvements in anxiety and anhedonia were also noted.”

Popular Science, May 2017
“If you’re looking to play it safe when it comes to illicit substances, look no further than the humble shroom. It’s non-addictive, hard to overdose on, and you can grow it yourself. And, according to a massive report by the Global Drug Survey, it sends the fewest people to the emergency room of any drug on the market.”

New York University, January 2013
“Patients who have benefited from psilocybin clinical research have reported less anxiety, improved quality of life, enhanced psychological and spiritual well-being, and a greater acceptance of the life-changes brought on by cancer.”

TheraPsil – Therapeutic Psilocybe for Canadians 
“We are a group of seven health professionals who seek to make psilocybin, a psychedelic medicine, legally available to Canadians in need of compassionate treatment for severe psychological distress.”

The Toronto Psychedelic Society  
“A community of communities with a multidisciplinary interest in the science, healing, education, and business of psychedelics. Join us for our events around the city.

Multidisciplinary Association for Psychedelic Studies Canada (MAPS Canada) 
“The Multidisciplinary Association for Psychedelic Studies (MAPS) Canada envisions a world where psychedelics and marijuana are safely and legally available for beneficial uses, and where research is governed by rigorous scientific evaluation of their risks and benefits.”

Psychedelic Psychotherapy Forum
“Canada’s premiere conference on psychedelic psychotherapy. The Forum engages mental health professionals and all others interested in advancing the ethical and legal use of psychedelic and plant medicines for healing, personal growth and transformation.”

Spirit Plant Medicine Conference
“People are discovering, rediscovering, and developing multiple uses of sacramental entheogenic medicines. The mission of the SPMC is to help guide this work forward by bringing a world-class international group of leading visionary voices to Vancouver.”

The 2020 Psilocybin Service Initiative of Oregon
Campaign for a 2020 ballot initiative to legalize psilocybe therapy in Oregon.

Decriminalize Denver 
Campaign for 2019 ballot initiative to decriminalize psilocybe mushrooms in Denver.

Here are some links for further reading and research about psilocybe mushrooms and microdosing.